Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group IND.191 -- A Phase II Study of AT9283 in Patients with Relapsed or Refractory Multiple Myeloma -- was centrally activated on 15 June 2010.

http://www.ctg.queensu.ca/trials/ind/i191/191.html

Canadian Cancer Trials Group MA.32 -- A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer -- was centrally activated today, 25 June 2010.

http://www.ctg.queensu.ca/trials/breast/ma32/ma32.html